{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T00:38:41Z","timestamp":1789605521262,"version":"build-2803163510"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2024,3,5]],"date-time":"2024-03-05T00:00:00Z","timestamp":1709596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,3,5]],"date-time":"2024-03-05T00:00:00Z","timestamp":1709596800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Gynecol Obstet"],"DOI":"10.1007\/s00404-024-07443-z","type":"journal-article","created":{"date-parts":[[2024,3,5]],"date-time":"2024-03-05T10:02:23Z","timestamp":1709632943000},"page":"1037-1048","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Association between fetal fraction of cell-free DNA and adverse pregnancy outcomes"],"prefix":"10.1007","volume":"310","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8682-5537","authenticated-orcid":false,"given":"Hakan","family":"Golbasi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6233-4207","authenticated-orcid":false,"given":"Burak","family":"Bayraktar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1844-1782","authenticated-orcid":false,"given":"Ceren","family":"Golbasi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9200-0208","authenticated-orcid":false,"given":"Ibrahim","family":"Omeroglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5307-8149","authenticated-orcid":false,"given":"Duygu","family":"Adiyaman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0029-2352","authenticated-orcid":false,"given":"Kaan Okan","family":"Alkan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4870-6945","authenticated-orcid":false,"given":"Taha Resid","family":"Ozdemir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6731-2461","authenticated-orcid":false,"given":"Ozge Kaya","family":"Ozer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2654-3698","authenticated-orcid":false,"given":"Berk","family":"Ozyilmaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4712-3927","authenticated-orcid":false,"given":"Atalay","family":"Ekin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,3,5]]},"reference":[{"key":"7443_CR1","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/S0140-6736(97)02174-0","volume":"350","author":"YM Lo","year":"1997","unstructured":"Lo YM, Corbetta N, Chamberlain PF, Rai V, Sargent IL, Redman CW et al (1997) Presence of fetal DNA in maternal plasma and serum. Lancet Lond Engl 350:485\u2013487. https:\/\/doi.org\/10.1016\/S0140-6736(97)02174-0","journal-title":"Lancet Lond Engl"},{"key":"7443_CR2","doi-asserted-by":"publisher","unstructured":"Practice Bulletin No. 163: Screening for fetal aneuploidy. Obstet Gynecol. 2016;127:e123\u201337. https:\/\/doi.org\/10.1097\/AOG.0000000000001406","DOI":"10.1097\/AOG.0000000000001406"},{"key":"7443_CR3","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1002\/pd.1700","volume":"27","author":"M Alberry","year":"2007","unstructured":"Alberry M, Maddocks D, Jones M, Abdel Hadi M, Abdel-Fattah S, Avent N et al (2007) Free fetal DNA in maternal plasma in anembryonic pregnancies: confirmation that the origin is the trophoblast. Prenat Diagn 27:415\u2013418. https:\/\/doi.org\/10.1002\/pd.1700","journal-title":"Prenat Diagn"},{"key":"7443_CR4","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1177\/1933719115584445","volume":"22","author":"Y Zhou","year":"2015","unstructured":"Zhou Y, Zhu Z, Gao Y, Yuan Y, Guo Y, Zhou L et al (2015) Effects of maternal and fetal characteristics on cell-free fetal DNA fraction in maternal plasma. Reprod Sci Thousand Oaks Calif 22:1429\u20131435. https:\/\/doi.org\/10.1177\/1933719115584445","journal-title":"Reprod Sci Thousand Oaks Calif"},{"key":"7443_CR5","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1002\/pd.4668","volume":"35","author":"S Gr\u00f6mminger","year":"2015","unstructured":"Gr\u00f6mminger S, Erkan S, Sch\u00f6ck U, Stangier K, Bonnet J, Schloo R et al (2015) The influence of low molecular weight heparin medication on plasma DNA in pregnant women. Prenat Diagn 35:1155\u20131157. https:\/\/doi.org\/10.1002\/pd.4668","journal-title":"Prenat Diagn"},{"key":"7443_CR6","doi-asserted-by":"publisher","unstructured":"\u0130leri\u0307 A, Karaca SY, \u0130leri\u0307 H, G\u00f6lba\u015fi H, Yildirim AG\u015e, Kutbay YB, et al. Effect of levothyroxine sodium \u0131ntake on the fetal fraction in non-\u0131nvasive prenatal testing: a cross-sectional study. J Clin Obstet Gynecol. 2022;32:106\u201310. https:\/\/doi.org\/10.5336\/jcog.2022-90002.","DOI":"10.5336\/jcog.2022-90002"},{"key":"7443_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jogoh.2023.102662","volume":"52","author":"A \u0130leri","year":"2023","unstructured":"\u0130leri A, Y\u0131ld\u0131r\u0131m Karaca S, \u0130leri H, Karaca \u0130, G\u00f6lba\u015f\u0131 H, \u00d6zer M et al (2023) The effect of progesterone supplementation in women with threatened miscarriage on fetal fraction in non-invasive prenatal testing: a matched case-control study. J Gynecol Obstet Hum Reprod 52:102662. https:\/\/doi.org\/10.1016\/j.jogoh.2023.102662","journal-title":"J Gynecol Obstet Hum Reprod"},{"key":"7443_CR8","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1002\/pd.5436","volume":"39","author":"M Kuhlmann-Capek","year":"2019","unstructured":"Kuhlmann-Capek M, Chiossi G, Singh P, Monsivais L, Lozovyy V, Gallagher L et al (2019) Effects of medication intake in early pregnancy on the fetal fraction of cell-free DNA testing. Prenat Diagn 39:361\u2013368. https:\/\/doi.org\/10.1002\/pd.5436","journal-title":"Prenat Diagn"},{"key":"7443_CR9","doi-asserted-by":"publisher","first-page":"453","DOI":"10.3390\/ijms18020453","volume":"18","author":"XL Peng","year":"2017","unstructured":"Peng XL, Jiang P (2017) Bioinformatics approaches for fetal DNA fraction estimation in noninvasive prenatal testing. Int J Mol Sci 18:453. https:\/\/doi.org\/10.3390\/ijms18020453","journal-title":"Int J Mol Sci"},{"key":"7443_CR10","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1038\/s41431-018-0271-7","volume":"27","author":"MS Hestand","year":"2019","unstructured":"Hestand MS, Bessem M, van Rijn P, de Menezes RX, Sie D, Bakker I et al (2019) Fetal fraction evaluation in non-invasive prenatal screening (NIPS). Eur J Hum Genet EJHG 27:198\u2013202. https:\/\/doi.org\/10.1038\/s41431-018-0271-7","journal-title":"Eur J Hum Genet EJHG"},{"key":"7443_CR11","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1002\/pd.6028","volume":"41","author":"PG Scheffer","year":"2021","unstructured":"Scheffer PG, Wirjosoekarto SAM, Becking EC, Weiss MM, Bax CJ, Oepkes D et al (2021) Association between low fetal fraction in cell-free DNA testing and adverse pregnancy outcome: a systematic review. Prenat Diagn 41:1287\u20131295. https:\/\/doi.org\/10.1002\/pd.6028","journal-title":"Prenat Diagn"},{"issue":"Suppl","key":"7443_CR12","doi-asserted-by":"publisher","first-page":"S17","DOI":"10.1016\/j.placenta.2010.06.018","volume":"32","author":"S Hahn","year":"2011","unstructured":"Hahn S, Rusterholz C, H\u00f6sli I, Lapaire O (2011) Cell-free nucleic acids as potential markers for preeclampsia. Placenta 32(Suppl):S17-20. https:\/\/doi.org\/10.1016\/j.placenta.2010.06.018","journal-title":"Placenta"},{"key":"7443_CR13","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1186\/1471-2350-10-120","volume":"10","author":"L Lazar","year":"2009","unstructured":"Lazar L, Rig\u00f3 J, Nagy B, Balogh K, Mak\u00f3 V, Cervenak L et al (2009) Relationship of circulating cell-free DNA levels to cell-free fetal DNA levels, clinical characteristics and laboratory parameters in preeclampsia. BMC Med Genet 10:120. https:\/\/doi.org\/10.1186\/1471-2350-10-120","journal-title":"BMC Med Genet"},{"key":"7443_CR14","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1159\/000236355","volume":"26","author":"M Al Nakib","year":"2009","unstructured":"Al Nakib M, Desbri\u00e8re R, Bonello N, Bretelle F, Boubli L, Gabert J et al (2009) Total and fetal cell-free DNA analysis in maternal blood as markers of placental insufficiency in intrauterine growth restriction. Fetal Diagn Ther 26:24\u201328. https:\/\/doi.org\/10.1159\/000236355","journal-title":"Fetal Diagn Ther"},{"issue":"231","key":"7443_CR15","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1016\/j.ajog.2016.02.009","volume":"215","author":"L Dugoff","year":"2016","unstructured":"Dugoff L, Barberio A, Whittaker PG, Schwartz N, Sehdev H, Bastek JA (2016) Cell-free DNA fetal fraction and preterm birth. Am J Obstet Gynecol 215(231):e1-7. https:\/\/doi.org\/10.1016\/j.ajog.2016.02.009","journal-title":"Am J Obstet Gynecol"},{"key":"7443_CR16","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1111\/1471-0528.15006","volume":"125","author":"N Chan","year":"2018","unstructured":"Chan N, Smet M-E, Sandow R, da Silva CF, McLennan A (2018) Implications of failure to achieve a result from prenatal maternal serum cell-free DNA testing: a historical cohort study. BJOG Int J Obstet Gynaecol 125:848\u2013855. https:\/\/doi.org\/10.1111\/1471-0528.15006","journal-title":"BJOG Int J Obstet Gynaecol"},{"key":"7443_CR17","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1055\/s-0039-1700860","volume":"37","author":"MA Clapp","year":"2020","unstructured":"Clapp MA, Berry M, Shook LL, Roberts PS, Goldfarb IT, Bernstein SN (2020) Low fetal fraction and birth weight in women with negative first-trimester cell-free DNA screening. Am J Perinatol 37:86\u201391. https:\/\/doi.org\/10.1055\/s-0039-1700860","journal-title":"Am J Perinatol"},{"key":"7443_CR18","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.preghy.2019.04.002","volume":"16","author":"KD Gerson","year":"2019","unstructured":"Gerson KD, Truong S, Haviland MJ, O\u2019Brien BM, Hacker MR, Spiel MH (2019) Low fetal fraction of cell-free DNA predicts placental dysfunction and hypertensive disease in pregnancy. Pregnancy Hypertens 16:148\u2013153. https:\/\/doi.org\/10.1016\/j.preghy.2019.04.002","journal-title":"Pregnancy Hypertens"},{"key":"7443_CR19","doi-asserted-by":"publisher","unstructured":"Adiyaman D, Konuralp Atakul B, Kuyucu M, Toklu G, Golbasi H, Koc A, et al. Can fetal fractions in the cell-free DNA test predict the onset of fetal growth restriction? J Perinat Med. 2020:\/j\/jpme.ahead-of-print\/jpm-2020-0010\/jpm-2020-0010.xml. https:\/\/doi.org\/10.1515\/jpm-2020-0010.","DOI":"10.1515\/jpm-2020-0010"},{"key":"7443_CR20","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1002\/pd.4779","volume":"36","author":"I Krishna","year":"2016","unstructured":"Krishna I, Badell M, Loucks TL, Lindsay M, Samuel A (2016) Adverse perinatal outcomes are more frequent in pregnancies with a low fetal fraction result on noninvasive prenatal testing. Prenat Diagn 36:210\u2013215. https:\/\/doi.org\/10.1002\/pd.4779","journal-title":"Prenat Diagn"},{"key":"7443_CR21","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.preghy.2020.07.015","volume":"22","author":"X Yuan","year":"2020","unstructured":"Yuan X, Zhou L, Zhang B, Wang H, Yu B, Xu J (2020) Association between low fetal fraction of cell free DNA at the early second-trimester and adverse pregnancy outcomes. Pregnancy Hypertens 22:101\u2013108. https:\/\/doi.org\/10.1016\/j.preghy.2020.07.015","journal-title":"Pregnancy Hypertens"},{"key":"7443_CR22","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1097\/AOG.0000000000002728","volume":"132","author":"P Benn","year":"2018","unstructured":"Benn P, Valenti E, Shah S, Martin K, Demko Z (2018) Factors associated with informative redraw after an initial no result in noninvasive prenatal testing. Obstet Gynecol 132:428\u2013435. https:\/\/doi.org\/10.1097\/AOG.0000000000002728","journal-title":"Obstet Gynecol"},{"key":"7443_CR23","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.preghy.2021.09.008","volume":"27","author":"LA Magee","year":"2022","unstructured":"Magee LA, Brown MA, Hall DR, Gupte S, Hennessy A, Karumanchi SA et al (2022) The 2021 International Society for the Study of Hypertension in pregnancy classification, diagnosis & management recommendations for international practice. Pregnancy Hypertens 27:148\u2013169. https:\/\/doi.org\/10.1016\/j.preghy.2021.09.008","journal-title":"Pregnancy Hypertens"},{"key":"7443_CR24","doi-asserted-by":"publisher","unstructured":"International Association of Diabetes and Pregnancy Study Groups Consensus Panel, Metzger BE, Gabbe SG, Persson B, Buchanan TA, Catalano PA, et al. International association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Diabetes Care. 2010;33:676\u201382. https:\/\/doi.org\/10.2337\/dc09-1848.","DOI":"10.2337\/dc09-1848"},{"key":"7443_CR25","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1016\/S0140-6736(18)31877-4","volume":"393","author":"C Ovadia","year":"2019","unstructured":"Ovadia C, Seed PT, Sklavounos A, Geenes V, Di Ilio C, Chambers J et al (2019) Association of adverse perinatal outcomes of intrahepatic cholestasis of pregnancy with biochemical markers: results of aggregate and individual patient data meta-analyses. Lancet Lond Engl 393:899\u2013909. https:\/\/doi.org\/10.1016\/S0140-6736(18)31877-4","journal-title":"Lancet Lond Engl"},{"key":"7443_CR26","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1016\/S0140-6736(14)60932-6","volume":"384","author":"J Villar","year":"2014","unstructured":"Villar J, Cheikh Ismail L, Victora CG, Ohuma EO, Bertino E, Altman DG et al (2014) International standards for newborn weight, length, and head circumference by gestational age and sex: the Newborn Cross-Sectional Study of the INTERGROWTH-21st Project. Lancet Lond Engl 384:857\u2013868. https:\/\/doi.org\/10.1016\/S0140-6736(14)60932-6","journal-title":"Lancet Lond Engl"},{"key":"7443_CR27","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1002\/pd.1645","volume":"27","author":"A Crowley","year":"2007","unstructured":"Crowley A, Martin C, Fitzpatrick P, Sheils O, O\u2019Herlihy C, O\u2019Leary JJ et al (2007) Free fetal DNA is not increased before 20 weeks in intrauterine growth restriction or pre-eclampsia. Prenat Diagn 27:174\u2013179. https:\/\/doi.org\/10.1002\/pd.1645","journal-title":"Prenat Diagn"},{"key":"7443_CR28","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1016\/j.ajog.2003.12.019","volume":"190","author":"RJ Levine","year":"2004","unstructured":"Levine RJ, Qian C, Leshane ES, Yu KF, England LJ, Schisterman EF et al (2004) Two-stage elevation of cell-free fetal DNA in maternal sera before onset of preeclampsia. Am J Obstet Gynecol 190:707\u2013713. https:\/\/doi.org\/10.1016\/j.ajog.2003.12.019","journal-title":"Am J Obstet Gynecol"},{"key":"7443_CR29","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1159\/000346806","volume":"33","author":"LCY Poon","year":"2013","unstructured":"Poon LCY, Musci T, Song K, Syngelaki A, Nicolaides KH (2013) Maternal plasma cell-free fetal and maternal DNA at 11\u201313 weeks\u2019 gestation: relation to fetal and maternal characteristics and pregnancy outcomes. Fetal Diagn Ther 33:215\u2013223. https:\/\/doi.org\/10.1159\/000346806","journal-title":"Fetal Diagn Ther"},{"key":"7443_CR30","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.placenta.2012.11.001","volume":"34","author":"MJ Kim","year":"2013","unstructured":"Kim MJ, Kim SY, Park SY, Ahn HK, Chung JH, Ryu HM (2013) Association of fetal-derived hypermethylated RASSF1A concentration in placenta-mediated pregnancy complications. Placenta 34:57\u201361. https:\/\/doi.org\/10.1016\/j.placenta.2012.11.001","journal-title":"Placenta"},{"key":"7443_CR31","doi-asserted-by":"publisher","first-page":"205031211984370","DOI":"10.1177\/2050312119843700","volume":"7","author":"S Braunthal","year":"2019","unstructured":"Braunthal S, Brateanu A (2019) Hypertension in pregnancy: pathophysiology and treatment. SAGE Open Med 7:2050312119843700. https:\/\/doi.org\/10.1177\/2050312119843700","journal-title":"SAGE Open Med"},{"key":"7443_CR32","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1007\/s40291-018-0353-9","volume":"22","author":"D Morano","year":"2018","unstructured":"Morano D, Rossi S, Lapucci C, Pittalis MC, Farina A (2018) Cell-free DNA (cfDNA) fetal fraction in early- and late-onset fetal growth restriction. Mol Diagn Ther 22:613\u2013619. https:\/\/doi.org\/10.1007\/s40291-018-0353-9","journal-title":"Mol Diagn Ther"},{"key":"7443_CR33","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.ejogrb.2012.09.006","volume":"166","author":"W Stein","year":"2013","unstructured":"Stein W, M\u00fcller S, Gutensohn K, Emons G, Legler T (2013) Cell-free fetal DNA and adverse outcome in low risk pregnancies. Eur J Obstet Gynecol Reprod Biol 166:10\u201313. https:\/\/doi.org\/10.1016\/j.ejogrb.2012.09.006","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"7443_CR34","doi-asserted-by":"publisher","first-page":"3342","DOI":"10.3390\/ijms19113342","volume":"19","author":"JF Plows","year":"2018","unstructured":"Plows JF, Stanley JL, Baker PN, Reynolds CM, Vickers MH (2018) The pathophysiology of gestational diabetes mellitus. Int J Mol Sci 19:3342. https:\/\/doi.org\/10.3390\/ijms19113342","journal-title":"Int J Mol Sci"},{"key":"7443_CR35","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1515\/jpm-2022-0050","volume":"50","author":"H Golbasi","year":"2022","unstructured":"Golbasi H, Bayraktar B, Golbasi C, Omeroglu I, Adiyaman D, Sever B et al (2022) Can sonographic imaging of the fetal pancreas predict perinatal outcomes in gestational diabetes mellitus? J Perinat Med 50:1189\u20131197. https:\/\/doi.org\/10.1515\/jpm-2022-0050","journal-title":"J Perinat Med"}],"container-title":["Archives of Gynecology and Obstetrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00404-024-07443-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00404-024-07443-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00404-024-07443-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,18]],"date-time":"2024-07-18T14:09:07Z","timestamp":1721311747000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00404-024-07443-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,5]]},"references-count":35,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2024,8]]}},"alternative-id":["7443"],"URL":"https:\/\/doi.org\/10.1007\/s00404-024-07443-z","relation":{},"ISSN":["1432-0711"],"issn-type":[{"value":"1432-0711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,5]]},"assertion":[{"value":"16 November 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 February 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 March 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Authors state no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Research involving human subjects complied with all relevant national regulations, institutional policies and is in accordance with the tenets of the Helsinki Declaration (as revised in 2013), and has been approved by the authors. The Local Institutional Review Board approval number: 2021\/04\u201318.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individuals included in this study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}